BACKGROUND: Few studies have assessed adherence to non-vitamin K antagonist oral
anticoagulants (NOACs), especially using contemporary data now that multiple NOACs are …

BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used for
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …

Purpose Non-vitamin K antagonist oral anticoagulant medications are increasingly used for
stroke prophylaxis in patients with nonvalvular atrial fibrillation (NVAF). This study aimed to …

BACKGROUND: Adherence to oral anticoagulant (OAC) agents is important for patients with
nonvalvular atrial fibrillation (NVAF) to prevent potentially severe adverse events …

Aim To assess persistence and adherence to rivaroxaban, dabigatran, and vitamin K
antagonist (VKA) treatment in primary care patients with non-valvular atrial fibrillation (AF) …

Due to a rapid decline of protective anticoagulation with novel oral anticoagulants (NOACs)
when doses are omitted, a high degree medication adherence to NOACs is essential for …

Objectives: Our study examined the impact of adherence to novel oral anticoagulants
[NOACs-dabigatran and rivaroxaban] on ischemic-stroke (IS), major-bleeding (MB), deep …

Background Differences in adherence may represent drug properties (eg dosing interval) or
patient experiences while on treatment. Adherence to direct oral anticoagulants (DOACs) in …

Background The direct oral anticoagulants (DOACs) reduce the risk of stroke in moderate to
high-risk patients with non-valvular atrial fibrillation (AF). Yet, concerns remain regarding its …

Introduction Adherence to non-vitamin-K oral anticoagulants (NOACs) may be lower than to
vitamin K antagonists because NOACs do not require routine monitoring. Objective We …